HALOGENATION OF FLUOROALKYL-SUBSTITUTED β-KETOESTERS

DOI: 10.1007/BF01141716

Source and publish data:

Bulletin of the Academy of Sciences of the USSR Division of Chemical Science p. 1016 - 1022 (1984)

Update date:2022-08-04

Topics:

Authors:

Saloutin, V. I.

Skryabina, Z. E.

Rudaya, M. N.

Pashkevich, K. I.

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1007/BF01141716

Full text of DOI:10.1007/BF01141716

Products guided by the article

Product name:Butanoic acid, 2,2-dibromo-4,4,4-trifluoro-3-oxo-, methyl ester

Cas No:93032-04-3

R&D Labs maybe for 93032-04-3

Goldwills Pharmaceuticals Co., Ltd.

Contact:0916-2237889 13991621155

Address:North Suburb of Hanzhong city, Shaanxi Province
Tomo Pharma Chem Co., Limited

Contact:+86-158-05817090

Address:ROOM 9F, FLAT 2, GUODU DEVELOPING BLDG, No.182, ZHAOHUI ROAD
Shanghai Sinofluoro Scientific Co., Ltd

Contact:+86-21-64279360

Address:Room 1006,Building 3,#58 East Xinjian Road, Shanghai ,201100,China,
ZHEJIANG CHEMICAL INDUSTRY INSTITUTE TECHNOLOGY CO.,LTD(expird)

Contact:86-575-82730298

Address:shangyu
Xi'an HO-SHINE Bio-Technology Co., Ltd

Contact:+86 (29) 8248-5435/18292020086

Address:No.6 Shiyuan Road Xian City Shaanxi Province, 710048 China

Relevant to this article

Doi:10.1021/jo01070a021
(1961)
Kinetics and Mechanism of Hydrolysis of 4-Phenylallophanates

Doi:10.1039/P29840001233
(1984)
The Ability of an α-Aminoisobutyric Acid Residue to Promote Helical Folding in Oligopeptides

Doi:10.1246/bcsj.58.1731
(1985)
A competitive and highly selective 7-, 6- And 5-annulation with 1,3-migration through C-H and N-H-alkyne coupling

Doi:10.1039/c9cc07360d
(2020)
Structural characterisation of a series of acetylide-functionalised oligopyridines and the synthesis, characterisation and optical spectroscopy of platinum di-ynes and poly-ynes containing oligopyridyl linker groups in the backbone

Doi:10.1039/b110658a
(2002)
Design and synthesis of 4-anilinoquinazolines as Raf kinase inhibitors. Part 1. Selective B-Raf/B-Raf^V600E and potent EGFR/VEGFR2 inhibitory 4-(3-hydroxyanilino)-6-(1H-1,2,3-triazol-4-yl)quinazolines

Doi:10.1016/j.bioorg.2021.104715
(2021)

Article Doi